Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial. Kayvon Modjarrad , Christine C Roberts , Kristin T Mills , Amy R Castellano , Kristopher Paolino , Kar Muthumani , Emma L Reuschel , Merlin L Robb , Trina Racine , Myoung-Don Oh , Claude Lamarre , Faraz I Zaidi , Jean Boyer , Sagar B Kudchodkar , Moonsup Jeong , Janice M Darden , Young K Park , Paul T Scott , Celine Remigio , Ajay P Parikh , Megan C Wise , Ami Patel , Elizabeth K Duperret , Kevin Y Kim , Hyeree Choi , Scott White , Mark Bagarazzi , Jeanine M May , Deborah Kane , Hyojin Lee , Gary Kobinger , Nelson L Michael , David B Weiner , Stephen J Thomas , Joel N Maslow The Lancet Infectious Diseases（2019）
摘要
US Department of the Army and GeneOne Life Science.
更多 查看译文
AI 理解论文
溯源树
样例
